Form 4 for NVAX NOVAVAX INC
Accepted 2024-12-13 00:00:00 ET · period of report 2024-12-11 · accession 0001593968-24-001472 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-13 | 2024-12-11 | NVAX | Casey Mark J | EVP, CLO | M - OptEx | $0.00 | +41.9K | 41.9K | New | $0 |
| D | 2024-12-13 | 2024-12-11 | NVAX | Casey Mark J | EVP, CLO | F - Tax | $8.82 | -12.7K | 29.2K | -30% | -$112.1K |
| D | 2024-12-13 | 2024-12-11 | NVAX | Casey Mark J | EVP, CLO | M - OptEx | $0.00 | -41.9K | 83.8K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-11 | M | A | 41,900 | $0.00 | 41,900 | D | — | — | |
| 2 | Common | Common Stock | 2024-12-11 | F | D | 12,713 | $8.82 | 29,187 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2024-12-11 | M | D | 41,900 | $0.00 | 83,798 | D | $0.00 · — to 2033-12-11 | 41,900 Common Stock | (F1) One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date. |